Pharmacokinetics of long-acting lenacapavir in participants with hepatic or renal impairment. Jogiraju V, Weber E, Hindman J, West S, et al. Antimicrob Agents Chemother 2024 Mar 8:e0134423. doi: 10.1128/aac.01344.

Read + Share

Amedeo Smart

Independent Medical Education

Jogiraju V, Weber E, Hindman J, West S, et al. Pharmacokinetics of long-acting lenacapavir in participants with hepatic or renal impairment. Antimicrob Agents Chemother 2024 Mar 8:e0134423. doi: 10.1128/aac.01344.
PMID: 38456707